A comparative study of mesenchymal stem cell transplantation and NTG-101 molecular therapy to treat degenerative disc disease

Cellular replacement therapy using mesenchymal stem cells (MSCs) and/or the delivery of growth factors are at the forefront of minimally invasive biological treatment options for Degenerative Disc Disease (DDD). In this study, we compared the therapeutic potential of a novel drug candidate, NTG-101...

Descripción completa

Detalles Bibliográficos
Autores principales: Matta, Ajay, Karim, Muhammad Zia, Gerami, Hoda, Benigno, Bettina, Erwin, W. Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292352/
https://www.ncbi.nlm.nih.gov/pubmed/34285277
http://dx.doi.org/10.1038/s41598-021-94173-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292352/
https://www.ncbi.nlm.nih.gov/pubmed/34285277
http://dx.doi.org/10.1038/s41598-021-94173-w

Ejemplares similares